close

Have questions? We can help.

Frequently Asked Questions

Please select from the following topics:

About Qsymia Engage

What are the eligibility requirements for Qsymia Engage?

You must be 18 or older to participate in the Qsymia Engage Home Delivery Pharmacy Program and receive the requested product. You must have a valid email address. You must have a prescription for Qsymia submitted to Medvantx by your Healthcare Provider. You must have a valid physical mailing address in the United States, Puerto Rico, Guam or the U.S. Virgin Islands. The Qsymia Engage Home Delivery Pharmacy Program requires a valid method of payment, credit or debit card, at time of product shipment. Checks or cash are not acceptable means of payment.

The Qsymia Engage Home Delivery Pharmacy Program is a cash-only program and does not process insurance claims. Patients or caregivers MAY NOT SUBMIT any purchase made through the Home Delivery Pharmacy program for reimbursement to any state or federal government healthcare program, and it cannot be applied towards your true out-of-pocket expenses.

Why can’t I claim Qsymia Engage purchases or expenses via insurance?

The Qsymia Engage Home Delivery Pharmacy Program is a cash-only program and does not process insurance claims. Patients or caregivers MAY NOT SUBMIT any purchase made through the Home Delivery Pharmacy program for reimbursement to any state or federal government healthcare program, and it cannot be applied towards true your out-of-pocket expenses.

How do the 6-Week New Patient and Titration packs work?

6-Week New Patient Pack
If you are a new patient, your doctor may have selected the 6-week New Patient Pack (a combination of the 14-day starter dose plus a 30-day prescription of Qsymia). The 6-week New Patient Pack gives you a 44-day supply of Qsymia but you pay only $98 for the 30-day prescription.*

6-Week Titration Pack
For continuing patients, your doctor may have prescribed a 30-day supply of Qsymia with a specified number of refills. They may have selected a 6-week Titration Pack (a combination of the 14-day titration dose plus a 30-day prescription of the highest dose Qsymia). The 6-week Titration Pack gives you a 44-day supply of Qsymia but you pay only $98 for the 30-day prescription.*

Regardless of which pack you order, it is important that you only take one Qsymia pill, once per day.

How do I manage my profile and personal health information authorization?

VIVUS respects your privacy and personal health information. As part of program registration, users are required to review and provide an electronic signature — authorizing Medvantx to share their personal health information with VIVUS. Upon registering, a copy of this Health Information Release will be emailed to you to keep for your records. Please email [email protected] if you wish to amend or revoke this authorization. Amending or revoking this authorization will unenroll you from the Qsymia Engage program.

How do I take advantage of the exclusive $98 pricing for all doses of Qsymia?

The exclusive flat-dose pricing of $98 is only available to registered users of Qsymia Engage whose doctors send their Qsymia prescriptions to Medvantx, the certified pharmacy partner for Qsymia.

Do you need a Qsymia prescription sent to Medvantx?

Speak with your doctor about the program. Please ask your doctor to visit Qsymia.com/prescribe to learn more about Qsymia Engage. There is a step-by-step guide to prescribing Qsymia for the Home Delivery Pharmacy program.

Ordering Qsymia via the Home Delivery Pharmacy is online only — the program does not support placing orders via phone.

What shipping options are available for my prescription?

Qsymia Engage provides customers three shipping options. The following lists the shipping and handling costs based on how an order is placed:

  Method Web Order Phone Order
 
Patient Packs or any 30-day Rx Standard $14.00 $27.00
2-Day $19.95 $32.95
Overnight $29.95 $42.95
 
90-day Rx Standard $0 $27.00
2-Day $25.95 $38.95
Overnight $35.95 $48.95

Standard Shipping: You can expect your medication in 5 to 7 business days. Standard shipping includes PO Box and Saturday delivery.

Expedited Shipping: You can expect your medication in 1 or 2 business days depending on your shipping choice.

There is no PO Box or Saturday delivery for expedited orders.

BACK TO TOP

Qsymia Engage Support and Help

BACK TO TOP

Delete my Profile

How do I manage my profile and personal health information authorization?

VIVUS respects your privacy and personal health information. As part of program registration, users are required to review and provide an electronic signature — authorizing Medvantx to share their personal health information with VIVUS. Upon registering, a copy of this Health Information Release will be emailed to you to keep for your records. If you wish to revoke this authorization, you may delete your profile. Please be aware that deleting your profile will unenroll you from the Qsymia Engage Program and remove all of your personal information from our system. This action can not be undone. If you wish to renew your participation at a later date, you will need to set up a new account.

BACK TO TOP

Home Delivery Pharmacy

I have questions about an order or my Home Delivery Pharmacy account.

Medvantx has extensive FAQs to support you through the entire ordering process and the home delivery pharmacy.

It is easy to access these materials as well as all your prescription, order and pharmacy account information. Simply log into your Qsymia Engage account and click on the Home Delivery Pharmacy link. This will take you to your secure, My Pharmacy Dashboard page. From there you can access your account and orders, as well as pharmacy frequently asked questions and support resources.

What is your return/refund policy?

Medvantx has extensive FAQs to support you through the entire ordering process and the home delivery pharmacy.

All sales are final and non-refundable. We will, however, accept for return and exchange unopened products damaged in transit (proof of damage required).

For damaged products, please contact Medvantx Customer Support at: 1 (844) 7-QSYMIA / 1 (844) 777-9642

BACK TO TOP

System Requirements and Supported Web Browsers

What web browsers does Qsymia Engage support?

PC’s, Laptops and Mobile Devices

We want to make sure that our patients have a successful online experience. Qsymia Engage supports the two most recent versions of the following web browsers (unless specified otherwise).

browser icon
Chrome
 
browser icon
Firefox
 
browser icon
Safari
(Apple only)
browser icon
Microsoft Edge
(Windows only)
browser icon
Internet Explorer 11
(Windows only)

Qsymia Engage is designed to be mobile responsive, which means it will resize and adjust to your screen when you visit on a mobile device. Qsymia Engage supports iOS 11 and up on Apple devices and Android 7.0 and up.

Did the system indicate you’re using an unsupported web browser? Try one of the others listed above on your PC, laptop or mobile device.

From time to time, we may update this information. Any changes will be effective when we post revised system requirements.

BACK TO TOP

*Home Delivery Pharmacy

Additional shipping and handling costs will apply. $98 pricing includes 6-week New Patient Packs, 6-week Titration Packs and all 30-day prescriptions. This is a cash-only program — insurance claims will not be processed.

Home Delivery Pharmacy Eligibility Requirements

Qsymia is indicated for patients 12 years of age and older. However, you must be 18 years or older to register for the Qsymia Engage Home Delivery Program and receive the requested product. If you are between 12-17 years of age, a caregiver must sign up on your behalf.

You must have a valid email address.

The Qsymia Engage Home Delivery Pharmacy Program is a cash-only program and does not process insurance claims. Patients or caregivers MAY NOT SUBMIT any purchase made through the Home Delivery Pharmacy program for reimbursement to any state or federal government healthcare program, and it cannot be applied towards my true out-of-pocket expenses.

You must have a prescription for Qsymia submitted to Medvantx by your Healthcare Provider.

You must have a valid physical mailing address in the United States, Puerto Rico, Guam or the U.S. Virgin Islands.

The Qsymia Engage Home Delivery Pharmacy Program requires a valid method of payment, credit or debit card, at time of product shipment. Checks or cash are not acceptable means of payment.

†Free Standard Shipping on 90-Day Web Orders

As of April 1, 2020 standard shipping and handling is now FREE on all 90-day web orders placed via the Qsymia Engage Home Delivery Pharmacy. 90-day prescriptions are not permitted in all states. Check with your healthcare provider.

Indication

Qsymia should be used together with a reduced-calorie diet and increased physical activity for chronic weight management in:

  • Adults with an initial body mass index (BMI) of:
    • 30 kg/m2 or greater (obese) or
    • 27 kg/m2 or greater (overweight) in the presence of at least one weight-related medical condition such as high blood pressure, type 2 diabetes, or high cholesterol
  • Pediatric patients aged 12 years and older with an initial BMI in the 95th percentile or greater standardized for age and sex

LIMITATIONS OF USE:

  • It is not known if Qsymia changes your risk of heart problems or stroke or of death due to heart problems or stroke
  • It is not known if Qsymia is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products

Important Safety Information

Do not take Qsymia if you are pregnant, planning to become pregnant, or become pregnant during Qsymia treatment; have glaucoma; have thyroid problems (hyperthyroidism); are taking certain medicines called monoamine oxidase inhibitors (MAOIs) or have taken MAOIs in the past 14 days; are allergic to topiramate, sympathomimetic amines such as phentermine, or any of the ingredients in Qsymia. See the end of the Medication Guide for a complete list of ingredients in Qsymia.

QSYMIA CAN CAUSE SERIOUS SIDE EFFECTS, INCLUDING:

Birth defects (cleft lip/cleft palate). If you take Qsymia during pregnancy, your baby has a higher risk for birth defects called cleft lip and cleft palate. These defects can begin early in pregnancy, even before you know you are pregnant. Patients who are pregnant must not take Qsymia. Patients who can become pregnant should have a pregnancy test before taking Qsymia and every month while taking Qsymia and use effective birth control (contraception) consistently while taking Qsymia. Talk to your healthcare provider about how to prevent pregnancy.

If you become pregnant while taking Qsymia, stop taking Qsymia immediately, and tell your healthcare provider right away. Healthcare providers and patients should report all cases of pregnancy to FDA MedWatch at 1-800-FDA-1088, and the Qsymia Pregnancy Surveillance Program at 1-888-998-4887.

Qsymia may slow the increase in height in children 12 years and older.

Increases in heart rate. Qsymia can increase your heart rate at rest. Your healthcare provider should check your heart rate while you take Qsymia. Tell your healthcare provider if you experience, while at rest, a racing or pounding feeling in your chest lasting several minutes when taking Qsymia.

Visual field defects (independent of elevated intraocular pressure) have been reported in clinical trials and in postmarketing experience in patients receiving topiramate. In clinical trials, most of these events were reversible after topiramate discontinuation. If visual problems occur at any time during treatment, consider discontinuing Qsymia.

Suicidal thoughts or actions. Topiramate, an ingredient in Qsymia, may cause you to have suicidal thoughts or actions. Call your healthcare provider right away if you have any of these symptoms, especially if they are new, worse, or worry you: thoughts about suicide or dying; attempts to commit suicide; new or worse depression; new or worse anxiety; feeling agitated or restless; panic attacks; trouble sleeping (insomnia); new or worse irritability; acting aggressive, being angry, or violent; acting on dangerous impulses; an extreme increase in activity or talking (mania); other unusual changes in behavior or mood.

Serious eye problems, which include any sudden decrease in vision, with or without eye pain and redness or a blockage of fluid in the eye causing increased pressure in the eye (secondary angle closure glaucoma). These problems can lead to permanent vision loss if not treated. Tell your healthcare provider right away if you have any new eye symptoms.

Qsymia may cause a severe rash with blisters and peeling skin, especially around the mouth, nose, eyes, and genitals (Stevens-Johnson Syndrome). Qsymia may also cause a rash with blisters and peeling skin over much of the body that may be life threatening (Toxic Epidermal Necrolysis). Call your healthcare provider right away if you develop a skin rash or blisters.

COMMON SIDE EFFECTS OF QSYMIA IN ADULTS INCLUDE:

Numbness or tingling in the hands, arms, feet, or face (paraesthesia); dizziness; changes in the way foods taste or loss of taste (dysgeusia); trouble sleeping (insomnia); constipation; and dry mouth.

COMMON SIDE EFFECTS OF QSYMIA IN CHILDREN 12 YEARS OLD AND OLDER INCLUDE:

Depression, dizziness, joint pain, fever, flu, and ankle sprain.

POSSIBLE SIDE EFFECTS OF QSYMIA INCLUDE:

Mood changes and trouble sleeping. Qsymia may cause depression or mood problems, and trouble sleeping. Tell your healthcare provider if symptoms occur.

Concentration, memory, and speech difficulties. Qsymia may affect how you think and cause confusion, problems with concentration, attention, memory or speech. Tell your healthcare provider if symptoms occur.

Increases of acid in bloodstream (metabolic acidosis). If left untreated, metabolic acidosis can cause brittle or soft bones (osteoporosis, osteomalacia, osteopenia), kidney stones, can slow the rate of growth in children, and may possibly harm your baby if you are pregnant. Metabolic acidosis can happen with or without symptoms. Sometimes people with metabolic acidosis will: feel tired, not feel hungry (loss of appetite), feel changes in heartbeat, or have trouble thinking clearly. Your healthcare provider should do a blood test to measure the level of acid in your blood before and during your treatment with Qsymia.

Low blood sugar (hypoglycemia) in people with type 2 diabetes mellitus who also take medicines used to treat type 2 diabetes mellitus. Weight loss can cause low blood sugar in people with type 2 diabetes mellitus who also take medicines used to treat type 2 diabetes mellitus (such as insulin or sulfonylureas). You should check your blood sugar before you start taking Qsymia and while you take Qsymia.

High blood pressure medicines. If you are taking medicines for your blood pressure, your doctor may need to adjust these medicines while taking Qsymia.

Central Nervous System (CNS) side effects. The use of prescription sleep aids, anxiety medicines, or drinking alcohol with Qsymia may cause an increase in CNS symptoms such as dizziness and light-headedness. Do not drink alcohol with Qsymia.

Possible seizures if you stop taking Qsymia too fast. Seizures may happen in people who may or may not have had seizures in the past if you stop Qsymia too fast. Your healthcare provider will tell you how to stop taking Qsymia slowly.

Kidney stones. Drink plenty of fluids when taking Qsymia to help decrease your chances of getting kidney stones. If you get severe side or back pain, and/or blood in your urine, call your healthcare provider.

Decreased sweating and increased body temperature (fever). People should be watched for signs of decreased sweating and fever, especially in hot temperatures. Some people may need to be hospitalized for this condition.

Qsymia capsules contain the inactive ingredient FD&C Yellow No. 5 (tartrazine) which can cause allergic-type reactions (including bronchial asthma) in certain people, especially people who also have an allergy to aspirin.

Tell your healthcare provider if you have any side effect that bothers you or does not go away. These are not all of the possible side effects of Qsymia. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to VIVUS LLC at 1‑888‑998‑4887 or FDA at 1‑800‑FDA‑1088 or www.fda.gov/medwatch.

Please read the Qsymia Medication Guide and Full Prescribing Information.

The Q and Me® Patient Support Program is based on the LEARN® Program provided under copyright license (September 15, 2010). All rights reserved.

Indication

Qsymia is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management inadults with an initial body mass index (BMI)…

Important Safety Information

Do not take Qsymia if you are pregnant, planning to become pregnant, or become pregnant during Qsymia treatment; have glaucoma; have thyroid problems (hyperthyroidism); are taking certain medicines called monoamine oxidase inhibitors…

READ MORE